Integrated Core Strategies (US) LLC 13D/13G Filings for Enanta Pharmaceuticals, Inc. (ENTA)

Integrated Core Strategies (US) LLC 13D and 13G filings for Enanta Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-01-22
4:01 pm
Purchase
2025-01-1413GEnanta Pharmaceuticals, Inc.
ENTA
Integrated Core Strategies (US) LLC1,382,273
6.500%
1,382,273increase
(New Position)
Filing